Can low molecular weight heparin replace unfractionated heparin during peripheral arterial reconstruction? An open label prospective randomized controlled trialNORGREN, Lars.Journal of vascular surgery. 2004, Vol 39, Num 5, pp 977-984, issn 0741-5214, 8 p.Article

Stability of low molecular weight heparins stored in plastic syringesHAMILTON, Marlene A; STANG, Linda; ETCHES, Wai S et al.Thrombosis research. 2003, Vol 112, Num 1-2, pp 117-119, issn 0049-3848, 3 p.Conference Paper

Heparin induces mobilization of osteoprotegerin into the circulationVIK, Anders; BRODIN, Ellen; SVEINBJERNSSON, Baldur et al.Thrombosis and haemostasis. 2007, Vol 98, Num 1, pp 148-154, issn 0340-6245, 7 p.Article

An evaluation of low molecular weight heparin and hyperbaric oxygen treatment in the prevention of intra-abdominal adhesions and wound healingARIKAN, Soykan; ADAS, Gokhan; BARUT, Gul et al.The American journal of surgery. 2005, Vol 189, Num 2, pp 155-160, issn 0002-9610, 6 p.Article

Influence of low molecular weight heparin preparations on human internal thoracic artery contractionBUZUN, Leszek; KLESZCZEWSKI, Tomasz; KOSTRZEWSKA, Anna et al.European journal of cardio-thoracic surgery. 2004, Vol 26, Num 5, pp 951-955, issn 1010-7940, 5 p.Article

Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgeryBERGQVIST, D.British journal of surgery. 2004, Vol 91, Num 8, pp 965-974, issn 0007-1323, 10 p.Article

Randomized clinical trial of low molecular weight heparin with thigh-length or knee-length antiembolism stockings for patients undergoing surgeryHOWARD, A; ZACCAGNINI, D; ELLIS, M et al.British journal of surgery. 2004, Vol 91, Num 7, pp 842-847, issn 0007-1323, 6 p.Conference Paper

The anticoagulant capacity of plasmatic unfractionated heparin decreases at 23°CSTIEF, Thomas W.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 2, pp 209-212, issn 0957-5235, 4 p.Article

Thrombocytopenia and intra- cerebral complications associated with low-molecular-weight heparin treatment in patients undergoing total hip replacement a report of two casesLILIKAKIS, Anastasios K; PAPAPOLYCHRONIOU, Theodoros; MACHERAS, Georgios et al.Journal of bone and joint surgery. American volume. 2006, Vol 88A, Num 3, pp 634-638, issn 0021-9355, 5 p.Article

Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancyDEBEMARDO, Robert L; PERKINS, Rebecca B; LITTELL, Ramey D et al.Obstetrics and gynecology (New York. 1953). 2005, Vol 105, Num 5, pp 1006-1011, issn 0029-7844, 6 p., 1Article

Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: Assessment of a standardized periprocedural anticoagulation regimenDOUKETIS, James D; JOHNSON, Judith A; TURPIE, Alexander G et al.Archives of internal medicine (1960). 2004, Vol 164, Num 12, pp 1319-1326, issn 0003-9926, 8 p.Article

Use of antithrombotic agents during pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyBATES, Shannon M; GREER, Ian A; HIRSH, Jack et al.Chest. 2004, Vol 126, Num 3, pp 627S-644S, issn 0012-3692, SUPConference Paper

The effect of body weight on dalteparin pharmacokinetics : A preliminary studyYEE, J. Y. V; DUFFULL, S. B.European journal of clinical pharmacology. 2000, Vol 56, Num 4, pp 293-297, issn 0031-6970Article

Effect of low molecular weight heparin (fragmin) on bleeding after cardiac surgery. CommentaryCLARK, S. C; VITALE, N; ZACHARIAS, J et al.The Annals of thoracic surgery. 2000, Vol 69, Num 3, pp 762-765, issn 0003-4975Article

Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharidesQING MA; TOBU, Mahmut; FAREED, Jawed et al.Thrombosis research. 2007, Vol 119, Num 5, pp 653-661, issn 0049-3848, 9 p.Article

Héparines de bas poids moléculaire et prothèses valvulaires mécaniques = Low molecular weight heparin and mechanical valve prosthesesMEURIN, Philippe; ESMIEU-FOURNEL, Pierre Jean.STV. Sang thrombose vaisseaux. 2007, Vol 19, Num 5, pp 261-267, issn 0999-7385, 7 p.Article

Effects of unfractionated heparin and low-molecular-weight heparin on colonic anastomoses in the presence of experimental peritonitisGUNERHAN, Yusuf; KOKSAL, Neset; GUL, Ozden et al.European surgical research. 2006, Vol 38, Num 3, pp 353-357, issn 0014-312X, 5 p.Article

Treatment of left ventricular thrombi with a low molecular weight heparinMEURIN, Philippe; TABET, Jean Yves; RENAUD, Nathalie et al.International journal of cardiology. 2005, Vol 98, Num 2, pp 319-323, issn 0167-5273, 5 p.Article

A contemporary assessment of low-molecular-weight heparin for the treatment of acute coronary syndromes : Factoring in new trials and meta-analysis dataTOPOL, Eric J.The American heart journal. 2005, Vol 149, Num 4, pp S100-S106, issn 0002-8703, SUPConference Paper

Differential regulation of thrombin activatable fibrinolytic inhibitor by low molecular weight heparins : Pharmacologic implicationsFLORIAN-KUJAWSKI, M; HOPPENSTEADT, D; MADDINENI, J et al.International angiology. 2004, Vol 23, Num 4, pp 346-354, issn 0392-9590, 9 p.Article

Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyHIRSH, Jack; RASCHKE, Robert.Chest. 2004, Vol 126, Num 3, pp 188S-203S, issn 0012-3692, SUPConference Paper

An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trialMASSICOTTE, Patricia; JULIAN, Jim A; GENT, Michael et al.Thrombosis research. 2003, Vol 109, Num 2-3, pp 85-92, issn 0049-3848, 8 p.Article

Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin-sodium) in pediatric patientsMASSICOTTE, Patricia; JULIAN, Jim A; ANDREW, Maureen et al.Thrombosis research. 2003, Vol 109, Num 2-3, pp 93-99, issn 0049-3848, 7 p.Article

Use patterns of low-molecular weight heparin and the impact on length of stay in patients hospitalized for atrial fibrillationKIM, Michael H; DECENA, Benigno F; BRUCKMAN, David et al.The American heart journal. 2003, Vol 145, Num 4, pp 665-669, issn 0002-8703, 5 p.Article

Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: A model for assessing intrinsic thromboresistanceYOUFU LI; RODRIQUEZ, Miguel; SPENCER, Frederick A et al.Journal of thrombosis and thrombolysis. 2002, Vol 14, Num 2, pp 123-129, issn 0929-5305, 7 p.Article